Back
#1
25.7%
Top 20%
25.7%
Top 0.3%
20.5%
Top 4%
2.5%
Top 5%
2.2%
Top 1%
2.2%
Top 16%
1.8%
Top 57%
1.3%
Top 0.3%
1.1%
Top 17%
1.1%
Top 7%
1.1%
Top 0.8%
0.8%
Top 94%
0.8%
Top 15%
0.8%
Top 4%
0.6%
Top 37%
0.6%
Top 2%
0.5%
Top 64%
0.5%
Top 19%
0.5%
Top 2%
0.5%
Top 8%
0.5%
Top 63%
0.5%
Immunogenicity of heterologous prime/boost inactivated and mRNA COVID-19 vaccine
2021-11-21
allergy and immunology
Title + abstract only
View on medRxiv
Show abstract
IntroductionIn August 2021, Thailand imported the BNT162b2 mRNA COVID-19 vaccine. The prioritised group to receive the BNT162b2 vaccine were health professionals. The BNT162b2 vaccine scheduled for healthcare workers were two-dose regimen administered three weeks apart, the third dose booster in two-dose inactivated CoronaVac vaccine recipients or as a second dose in health professionals who had received the CoronaVac or adenoviral-vectored (ChAdOx1-S) vaccine as the first dose regardless of the...
Predicted journal destinations
1
Vaccines
131 training papers
2
PLOS ONE
1737 training papers
3
Vaccine
140 training papers
4
Journal of Medical Virology
95 training papers
5
Frontiers in Immunology
140 training papers
6
The Lancet Infectious Diseases
57 training papers
7
Clinical Infectious Diseases
219 training papers
8
BMJ Open
553 training papers
9
Human Vaccines & Immunotherapeutics
20 training papers
10
Frontiers in Medicine
99 training papers
11
Heliyon
57 training papers
12
npj Vaccines
18 training papers
13
Scientific Reports
701 training papers
14
Open Forum Infectious Diseases
124 training papers
15
Frontiers in Microbiology
36 training papers
16
Frontiers in Public Health
135 training papers
17
American Journal of Respiratory and Critical Care Medicine
23 training papers
18
Nature Communications
483 training papers
19
The Journal of Infectious Diseases
137 training papers
20
The Journal of Immunology
19 training papers
21
Medicine
29 training papers
22
eLife
262 training papers